The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective.
about
EMT in Breast Carcinoma-A ReviewTumour progression and metastasisNeuraminidase-1: a novel therapeutic target in multistage tumorigenesisEstrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.Micro-RNAs in regenerating lungs: an integrative systems biology analysis of murine influenza pneumonia.Role of TGF-β receptor III localization in polarity and breast cancer progressionBioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerβ-carotene Regulates the Murine Liver Microenvironment of a Metastatic Neuroblastoma.Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasionShould EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenograftsA novel role for the SUMO E3 ligase PIAS1 in cancer metastasisMesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro.Tumor microenvironment: a new treatment target for cancerZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis.The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKLTranscriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis.1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity.FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.Multiplatform-based molecular subtypes of non-small-cell lung cancer.Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.The role of miRNAs in cancer: from pathogenesis to therapeutic implications.Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment.Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer.Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion.Roles of long noncoding RNAs in gastric cancer and their clinical applications.MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.
P2860
Q26739625-53CEAA17-E52E-4B38-B311-E03EEC75D90EQ26766468-622AA645-5882-438B-AC47-5994259DFEC0Q28066130-6F0CCFD6-6467-4362-B13E-5E59F023E390Q33756426-EF23D8DB-0E72-4424-A499-725B80E19611Q33898629-D02C6733-CD0D-4FBA-A8B5-7893909A857EQ33941526-6413238D-5B8F-42F4-86FD-FFDC7A6F00B6Q33975908-6D25822C-4BCC-44C8-85F7-00740BDF3735Q34295621-968F60F9-1873-47AA-AB05-7C6C61D3F225Q34305289-382C1C22-7A64-4373-97F2-63216AC1BFD0Q34332451-34929ED6-DDD3-487D-9787-30CA8505594FQ34402141-5221EEEC-626B-4090-BB48-479D57C4478AQ34465302-88F6C6E2-B339-4BEC-A07E-7E8E5A80CE48Q34781180-F328C280-BDD4-4B6D-8CB3-18045FEA3858Q35159519-DD90899E-A9E5-43A1-9D20-CF44731522E2Q35361431-EF5C15B1-CA12-47EF-8D86-23756059EB54Q36261743-97147318-981F-45D1-96B9-0FB8960853D3Q36369146-DE64EAA3-B2E5-489B-9AD9-A0302A63BAC1Q36399064-D45EC588-CE28-44A1-99F8-1E324BD045B9Q36428009-ADDD92FA-A884-4AA1-882A-B4737346B926Q36944505-E9693FAE-448E-475C-9FAA-85722E1D4CB9Q37416907-B91555B1-8873-478A-8246-E35C915EFA37Q37420597-C23252CD-B105-4570-9B19-344FF1CF9286Q37617957-D50AF0B7-3B15-4C07-8C26-7F9410C9B716Q37684647-24C4B11F-E0E2-400D-BA88-232F6F536A98Q37687515-369F0381-C4FA-4955-9A2C-5595C3400EBEQ37691784-A934355C-FCFB-4086-B82A-E337B7734562Q38183485-AC2E6136-D390-49E2-8791-9F2E330A9701Q38203883-6DEE2A3B-3D9D-4F5C-80E5-2AD2A46FB97FQ38206587-D5D8AAC2-52CA-4A5B-BBAD-62837C983ED9Q38221290-7C89316C-ADB4-4864-8428-39BCD15E417EQ38393154-9C4FBFF1-4A8C-45C1-965C-D8E95ECEC382Q38650250-217AF6AF-7146-4ED0-89B1-105027B7CDF4Q38694772-BCE2F120-C57D-43C9-9FB5-8C38F3E53334Q38722079-9F56E15A-51A5-4547-9BC1-544B9CDA0D81Q38736890-C5F55D4B-AB1E-4E27-9294-7435B0BEA0B3Q38849666-1501D1C9-973C-49D6-AAA4-B4E1F907D568Q38897001-4DC573D0-B98A-4A19-96BC-C26EA0DCAA97Q39231590-BCED8296-59C6-43A9-8E53-3088E88ED71DQ41036251-9CD4D5E4-7803-462C-B498-04D429DF2611Q41125664-CE836FB9-3D86-4C47-B99B-E09F7394E8B1
P2860
The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of epithelial-mesench ...... tasis: a clinical perspective.
@en
The role of epithelial-mesench ...... tasis: a clinical perspective.
@nl
type
label
The role of epithelial-mesench ...... tasis: a clinical perspective.
@en
The role of epithelial-mesench ...... tasis: a clinical perspective.
@nl
prefLabel
The role of epithelial-mesench ...... tasis: a clinical perspective.
@en
The role of epithelial-mesench ...... tasis: a clinical perspective.
@nl
P2093
P2860
P356
P1476
The role of epithelial-mesench ...... tasis: a clinical perspective.
@en
P2093
Chad J Creighton
Don L Gibbons
Jonathan M Kurie
P2860
P304
P356
10.2147/CMAR.S35171
P407
P577
2013-07-31T00:00:00Z